The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh Muscles

Addison's Disease Clinical Trial

Official title:
An Open Label Pilot Study to Investigate the Effects of Two Preparations of Hydrocortisone (Hydrocortisone 100mg/ml and Solu-Cortef) Injected Intramuscularly Into the Deltoid and Upper Thigh Muscle During the State of Hypocortisolaemia

Status Recruiting

Clinical Trial Summary

The study will be looking at the cortisol profiles of hypocortisolaemic patients following 100mg injections of two hydrocortisone preparations (Solu-Cortef® & Hydrocortisone 100mg/ml). The investigators plan to use two methods of intramuscular injection to administer the preparations, one using a 1inch orange needle into the deltoid muscle and the other using a 1.25inch blue needle into the thigh muscle.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05350020
Study type	Interventional
Source	The London Clinic
Contact	Christine Topham
Phone	0203 219 3570
Email	clinicalresearch@thelondonclinic.co.uk
Status	Recruiting
Phase	Phase 4
Start date	March 14, 2022
Completion date	August 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00444119` - Survey in Patients With Chronic Adrenal Insufficiency in Germany	N/A
Completed	`NCT01452893` - Counterregulatory Hormone Production in Adrenal Insufficiency and Diabetes Type I	N/A
Not yet recruiting	`NCT01657123` - Exercise Capacity and Recovery in Addison's Disease	N/A
Completed	`NCT01063569` - Glucocorticoid Treatment in Addison's Disease	Phase 2/Phase 3
Not yet recruiting	`NCT04252001` - Growing up With the Young Endocrine Support System (YESS!)	N/A
Completed	`NCT00688987` - The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation	N/A
Completed	`NCT00004313` - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency	Phase 3